David Hallett serves as Chief Scientific Officer at RECURSION PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, David Hallett has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 17, 2026 involved selling 11,908 shares valued at $41.6K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | RXRX | $41.6K | Payment | 11,908 | $3.49 | Discretionary |
David Hallett currently holds 1,097,151 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), valued at approximately $0. This represents their equity stake as Chief Scientific Officer.
Based on SEC Form 4 filings, David Hallett has been a net neutral trader of RXRX stock. They have purchased $0 and sold $0 worth of shares.
David Hallett's most recent insider trade was on Feb 17, 2026, when they sold 11,908 shares at $3.49 per share.
Get notified when new Form 4 filings are submitted